{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T15:15:18Z","timestamp":1778771718793,"version":"3.51.4"},"reference-count":23,"publisher":"American Animal Hospital Association","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>\n                    The objective of this retrospective study was to report treatment outcomes in dogs with histiocytic sarcoma (HS) that were treated with nimustine (ACNU). This study evaluated data from 11 dogs including 5 with macroscopic tumors that were treated in the primary setting and 6 that underwent aggressive local therapy while being treated in the adjuvant setting. The median ACNU starting dose was 25 mg\/m\n                    <jats:sup>2<\/jats:sup>\n                    (range, 20\u201330 mg\/m\n                    <jats:sup>2<\/jats:sup>\n                    ; 3- to 5-wk intervals, 1\u20138 administrations). The median overall survival in the primary and adjuvant settings was 120 days (median progression-free survival [PFS], 63 days) and 400 days (median PFS, 212 days), respectively. Neutropenia was observed in eight cases (grade 1, n = 1; grade 2, n = 2; grade 3, n = 2; grade 4, n = 3) with nadir neutrophil count at 1 wk after ACNU administration. Mild gastrointestinal toxicity (grade 1\u20132) was observed in three cases. ACNU was well tolerated and showed a similar outcome to that seen for lomustine, which is a drug commonly used to treat canine HS, in terms of overall survival and PFS in the current study population. Further investigations will need to be undertaken to definitively determine if ACNU is an appropriate alternative to lomustine for the treatment of HS.\n                  <\/jats:p>","DOI":"10.5326\/jaaha-ms-6959","type":"journal-article","created":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T17:00:33Z","timestamp":1584464433000},"page":"146-151","source":"Crossref","is-referenced-by-count":6,"title":["Nimustine Treatment of 11 Cases of Canine Histiocytic Sarcoma"],"prefix":"10.5326","volume":"56","author":[{"given":"Hiroyuki","family":"Tani","sequence":"first","affiliation":[{"name":"From the Department of Veterinary Clinical Pathology (H.T., S.K., R.M., K.T., M.B.), Veterinary Medical Teaching Hospital (H.S.), Laboratory of Veterinary Radiology (A.F.-I., D.H.), Department of Veterinary Pathology (M.M.), and Department of Veterinary Nursing (D.A.), Nippon Veterinary and Life Science University, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sena","family":"Kurita","sequence":"additional","affiliation":[{"name":"From the Department of Veterinary Clinical Pathology (H.T., S.K., R.M., K.T., M.B.), Veterinary Medical Teaching Hospital (H.S.), Laboratory of Veterinary Radiology (A.F.-I., D.H.), Department of Veterinary Pathology (M.M.), and Department of Veterinary Nursing (D.A.), Nippon Veterinary and Life Science University, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Miyamoto","sequence":"additional","affiliation":[{"name":"From the Department of Veterinary Clinical Pathology (H.T., S.K., R.M., K.T., M.B.), Veterinary Medical Teaching Hospital (H.S.), Laboratory of Veterinary Radiology (A.F.-I., D.H.), Department of Veterinary Pathology (M.M.), and Department of Veterinary Nursing (D.A.), Nippon Veterinary and Life Science University, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harumi","family":"Sawada","sequence":"additional","affiliation":[{"name":"From the Department of Veterinary Clinical Pathology (H.T., S.K., R.M., K.T., M.B.), Veterinary Medical Teaching Hospital (H.S.), Laboratory of Veterinary Radiology (A.F.-I., D.H.), Department of Veterinary Pathology (M.M.), and Department of Veterinary Nursing (D.A.), Nippon Veterinary and Life Science University, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aki","family":"Fujiwara-Igarashi","sequence":"additional","affiliation":[{"name":"From the Department of Veterinary Clinical Pathology (H.T., S.K., R.M., K.T., M.B.), Veterinary Medical Teaching Hospital (H.S.), Laboratory of Veterinary Radiology (A.F.-I., D.H.), Department of Veterinary Pathology (M.M.), and Department of Veterinary Nursing (D.A.), Nippon Veterinary and Life Science University, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Michishita","sequence":"additional","affiliation":[{"name":"From the Department of Veterinary Clinical Pathology (H.T., S.K., R.M., K.T., M.B.), Veterinary Medical Teaching Hospital (H.S.), Laboratory of Veterinary Radiology (A.F.-I., D.H.), Department of Veterinary Pathology (M.M.), and Department of Veterinary Nursing (D.A.), Nippon Veterinary and Life Science University, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daigo","family":"Azakami","sequence":"additional","affiliation":[{"name":"From the Department of Veterinary Clinical Pathology (H.T., S.K., R.M., K.T., M.B.), Veterinary Medical Teaching Hospital (H.S.), Laboratory of Veterinary Radiology (A.F.-I., D.H.), Department of Veterinary Pathology (M.M.), and Department of Veterinary Nursing (D.A.), Nippon Veterinary and Life Science University, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Hasegawa","sequence":"additional","affiliation":[{"name":"From the Department of Veterinary Clinical Pathology (H.T., S.K., R.M., K.T., M.B.), Veterinary Medical Teaching Hospital (H.S.), Laboratory of Veterinary Radiology (A.F.-I., D.H.), Department of Veterinary Pathology (M.M.), and Department of Veterinary Nursing (D.A.), Nippon Veterinary and Life Science University, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyoichi","family":"Tamura","sequence":"additional","affiliation":[{"name":"From the Department of Veterinary Clinical Pathology (H.T., S.K., R.M., K.T., M.B.), Veterinary Medical Teaching Hospital (H.S.), Laboratory of Veterinary Radiology (A.F.-I., D.H.), Department of Veterinary Pathology (M.M.), and Department of Veterinary Nursing (D.A.), Nippon Veterinary and Life Science University, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Bonkobara","sequence":"additional","affiliation":[{"name":"From the Department of Veterinary Clinical Pathology (H.T., S.K., R.M., K.T., M.B.), Veterinary Medical Teaching Hospital (H.S.), Laboratory of Veterinary Radiology (A.F.-I., D.H.), Department of Veterinary Pathology (M.M.), and Department of Veterinary Nursing (D.A.), Nippon Veterinary and Life Science University, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3280","reference":[{"key":"bib1","series-title":"J Vet Intern Med","first-page":"121","article-title":"CCNU for the treatment of dogs with histiocytic sarcoma","volume":"21","author":"Skorupski\n              KA","year":"2007","unstructured":"Skorupski\n              KA\n            , CliffordCA, PaoloniMC, et al.\n          CCNU for the treatment of dogs with histiocytic sarcoma. J Vet Intern Med2007;21:121\u20136."},{"key":"bib2","series-title":"J Vet Intern Med","first-page":"1528","article-title":"Phase II, open-label trial of single-agent CCNU in dogs with previously untreated histiocytic sarcoma","volume":"24","author":"Rassnick\n              KM","year":"2010","unstructured":"Rassnick\n              KM\n            , MooreAS, RussellNC, et al.\n          Phase II, open-label trial of single-agent CCNU in dogs with previously untreated histiocytic sarcoma. J Vet Intern Med2010;24:1528\u201331."},{"key":"bib3","series-title":"J Vet Intern Med","first-page":"395","article-title":"Lomustine (CCNU) for the treatment of resistant lymphoma in dogs","volume":"13","author":"Moore\n              AS","year":"1999","unstructured":"Moore\n              AS\n            , LondonCA, WoodCA, et al.\n          Lomustine (CCNU) for the treatment of resistant lymphoma in dogs. J Vet Intern Med1999;13:395\u20138."},{"key":"bib4","series-title":"J Vet Intern Med","first-page":"601","article-title":"Treatment of canine mast cell tumors with CCNU (lomustine)","volume":"13","author":"Rassnick\n              KM","year":"1999","unstructured":"Rassnick\n              KM\n            , MooreAS, WilliamsLE, et al.\n          Treatment of canine mast cell tumors with CCNU (lomustine). J Vet Intern Med1999;13:601\u20135."},{"key":"bib5","series-title":"J Vet Intern Med","first-page":"75","article-title":"Hepatotoxicity associated with CCNU (lomustine) chemotherapy in dogs","volume":"18","author":"Kristal\n              O","year":"2004","unstructured":"Kristal\n              O\n            , RassnickKM, GliattoJM, et al.\n          Hepatotoxicity associated with CCNU (lomustine) chemotherapy in dogs. J Vet Intern Med2004;18:75\u201380."},{"key":"bib6","series-title":"J Vet Intern Med","first-page":"242","article-title":"Frequency and severity of neutropenia associated with Food and Drug Administration approved and compounded formulations of lomustine in dogs with cancer","volume":"30","author":"Burton\n              JH","year":"2016","unstructured":"Burton\n              JH\n            , StanleySD, KnychHK, et al.\n          Frequency and severity of neutropenia associated with Food and Drug Administration approved and compounded formulations of lomustine in dogs with cancer. J Vet Intern Med2016;30:242\u20136."},{"key":"bib7","series-title":"J Am Vet Med Assoc","first-page":"322","article-title":"Analysis of lomustine drug content in FDA-approved and compounded lomustine capsules","volume":"250","author":"KuKanich\n              B","year":"2017","unstructured":"KuKanich\n              B\n            , WarnerM, HahnK. Analysis of lomustine drug content in FDA-approved and compounded lomustine capsules. J Am Vet Med Assoc2017;250:322\u20136."},{"key":"bib8","series-title":"Cancer Chemother Pharmacol","first-page":"165","article-title":"Experimental and clinical effect of ACNU in Japan with emphasis on small-cell carcinoma of the lung","volume":"4","author":"Saijo\n              N","year":"1980","unstructured":"Saijo\n              N\n            , NiitaniH. Experimental and clinical effect of ACNU in Japan with emphasis on small-cell carcinoma of the lung. Cancer Chemother Pharmacol1980;4:165\u201371."},{"key":"bib9","series-title":"J Neurooncol","first-page":"57","article-title":"Nitrosourea efficacy in high-grade glioma: a survival gain analysis summarizing 504 cohorts with 24193 patients","volume":"88","author":"Wolff\n              JE","year":"2008","unstructured":"Wolff\n              JE\n            , BerrakS, Koontz WebbSE, et al.\n          Nitrosourea efficacy in high-grade glioma: a survival gain analysis summarizing 504 cohorts with 24193 patients. J Neurooncol2008;88:57\u201363."},{"key":"bib10","series-title":"PLoS One","first-page":"e0121225","article-title":"Influence of the expression level of O6-alkylguanine-DNA alkyltransferase on the formation of DNA interstrand crosslinks induced by chloroethylnitrosoureas in cells: a quantitation using high-performance liquid chromatography-mass spectrometry","volume":"10","author":"Li\n              L","year":"2015","unstructured":"Li\n              L\n            , LiS, SunG, et al.\n          Influence of the expression level of O6-alkylguanine-DNA alkyltransferase on the formation of DNA interstrand crosslinks induced by chloroethylnitrosoureas in cells: a quantitation using high-performance liquid chromatography-mass spectrometry. PLoS One2015;10:e0121225."},{"key":"bib11","series-title":"J Vet Med Sci","first-page":"895","article-title":"Phase I dose-escalation study of nimustine in tumor-bearing dogs","volume":"76","author":"Takahashi\n              M","year":"2014","unstructured":"Takahashi\n              M\n            , Goto-KoshinoY, FukushimaK, et al.\n          Phase I dose-escalation study of nimustine in tumor-bearing dogs. J Vet Med Sci2014;76:895\u20139."},{"key":"bib12","series-title":"J Vet Med Sci","first-page":"1343","article-title":"Establishment and biological characterization of canine histiocytic sarcoma cell lines","volume":"68","author":"Azakami\n              D","year":"2006","unstructured":"Azakami\n              D\n            , BonkobaraM, WashizuT, et al.\n          Establishment and biological characterization of canine histiocytic sarcoma cell lines. J Vet Med Sci2006;68:1343\u20136."},{"key":"bib13","series-title":"J Vet Diagn Invest","first-page":"127","article-title":"Pathological and immunohistochemical features of subdural histiocytic sarcomas in 15 dogs","volume":"23","author":"Ide\n              T","year":"2011","unstructured":"Ide\n              T\n            , UchidaK, KagawaY, et al.\n          Pathological and immunohistochemical features of subdural histiocytic sarcomas in 15 dogs. J Vet Diagn Invest2011;23:127\u201332."},{"key":"bib14","series-title":"J Comp Pathol","first-page":"188","article-title":"The class A macrophage scavenger receptor CD204 is a useful immunohistochemical marker of canine histiocytic sarcoma","volume":"148","author":"Kato\n              Y","year":"2013","unstructured":"Kato\n              Y\n            , MurakamiM, HoshinoY, et al.\n          The class A macrophage scavenger receptor CD204 is a useful immunohistochemical marker of canine histiocytic sarcoma. J Comp Pathol2013;148:188\u201396."},{"key":"bib15","series-title":"Vet Comp Oncol","first-page":"417","article-title":"Common terminology criteria for adverse events (VCOG-CTCAE) following chemotherapy or biological antineoplastic therapy in dogs and cats v1.1","volume":"14","year":"2016","unstructured":"Veterinary cooperative oncology group. Common terminology criteria for adverse events (VCOG-CTCAE) following chemotherapy or biological antineoplastic therapy in dogs and cats v1.1. Vet Comp Oncol2016;14:417\u201346."},{"key":"bib16","series-title":"J Small Anim Pract","first-page":"425","article-title":"Evaluation of a combination chemotherapy protocol including lomustine and doxorubicin in canine histiocytic sarcoma","volume":"56","author":"Cannon\n              C","year":"2015","unstructured":"Cannon\n              C\n            , BorgattiA, HensonM, et al.\n          Evaluation of a combination chemotherapy protocol including lomustine and doxorubicin in canine histiocytic sarcoma. J Small Anim Pract2015;56:425\u20139."},{"key":"bib17","series-title":"Vet Comp Oncol","first-page":"E30","article-title":"Epirubicin in the treatment of canine histiocytic sarcoma: sequential, alternating and rescue chemotherapy","volume":"16","author":"Mason\n              SL","year":"2018","unstructured":"Mason\n              SL\n            , FinotelloR, BlackwoodL. Epirubicin in the treatment of canine histiocytic sarcoma: sequential, alternating and rescue chemotherapy. Vet Comp Oncol2018;16:E30\u2013E7."},{"key":"bib18","series-title":"Vet Comp Oncol","first-page":"139","article-title":"Long-term survival in dogs with localized histiocytic sarcoma treated with CCNU as an adjuvant to local therapy","volume":"7","author":"Skorupski\n              KA","year":"2009","unstructured":"Skorupski\n              KA\n            , RodriguezCO, KrickEL, et al.\n          Long-term survival in dogs with localized histiocytic sarcoma treated with CCNU as an adjuvant to local therapy. Vet Comp Oncol2009;7:139\u201344."},{"key":"bib19","series-title":"Aust Vet J","first-page":"37","article-title":"Chemotherapy for dogs with lymph node metastasis from histiocytic sarcomas","volume":"95","author":"Moore\n              AS","year":"2017","unstructured":"Moore\n              AS\n            , TaylorDP, ReppasG, et al.\n          Chemotherapy for dogs with lymph node metastasis from histiocytic sarcomas. Aust Vet J2017;95:37\u201340."},{"key":"bib20","series-title":"Vet Comp Oncol","first-page":"658","article-title":"Primary pulmonary histiocytic sarcoma in dogs: A retrospective analysis of 37 cases (2000-2015)","volume":"16","author":"Marlowe\n              KW","year":"2018","unstructured":"Marlowe\n              KW\n            , RobatCS, ClarkeDL, et al.\n          Primary pulmonary histiocytic sarcoma in dogs: A retrospective analysis of 37 cases (2000-2015). Vet Comp Oncol2018;16:658\u201363."},{"key":"bib21","series-title":"J Am Vet Med Assoc","first-page":"90","article-title":"Evaluation and comparison of outcomes in dogs with periarticular and nonperiarticular histiocytic sarcoma","volume":"239","author":"Klahn\n              SL","year":"2011","unstructured":"Klahn\n              SL\n            , KitchellBE, DervisisNG. Evaluation and comparison of outcomes in dogs with periarticular and nonperiarticular histiocytic sarcoma. J Am Vet Med Assoc2011;239:90\u20136."},{"key":"bib22","series-title":"Vet Comp Oncol","first-page":"1171","article-title":"Clinical prognostic factors in canine histiocytic sarcoma","volume":"15","author":"Dervisis\n              NG","year":"2017","unstructured":"Dervisis\n              NG\n            , KiupelM, QinQ, et al.\n          Clinical prognostic factors in canine histiocytic sarcoma. Vet Comp Oncol2017;15:1171\u201380."},{"key":"bib23","series-title":"J Vet Intern Med","first-page":"607","article-title":"Histiocytic sarcoma with central nervous system involvement in dogs: 19 cases (2006-2012)","volume":"29","author":"Mariani\n              CL","year":"2015","unstructured":"Mariani\n              CL\n            , JenningsMK, OlbyNJ, et al.\n          Histiocytic sarcoma with central nervous system involvement in dogs: 19 cases (2006-2012). J Vet Intern Med2015;29:607\u201313."}],"container-title":["Journal of the American Animal Hospital Association"],"original-title":[],"link":[{"URL":"https:\/\/jaaha.kglmeridian.com\/view\/journals\/aaha\/56\/3\/article-p146.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/meridian.allenpress.com\/jaaha\/article-pdf\/56\/3\/146\/2466714\/jaaha-ms-6959.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/jaaha.kglmeridian.com\/downloadpdf\/journals\/aaha\/56\/3\/article-p146.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/jaaha.kglmeridian.com\/downloadpdf\/journals\/aaha\/56\/3\/article-p146.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T16:04:59Z","timestamp":1763741099000},"score":1,"resource":{"primary":{"URL":"https:\/\/jaaha.kglmeridian.com\/view\/journals\/aaha\/56\/3\/article-p146.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":23,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.5326\/jaaha-ms-6959","relation":{},"ISSN":["0587-2871","1547-3317"],"issn-type":[{"value":"0587-2871","type":"print"},{"value":"1547-3317","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020]]}}}